Amy Abernethy, the principal deputy commissioner and acting CIO of the Food and Drug Administration, discusses the agency’s plans to update its data strategy and technology to move with the speed of scientific advancement. Abernethy also explains the importance of leveraging innovative technology like AI and blockchain, migrating to the cloud, and public-private partnerships supporting the agency’s COVID-19 response efforts.
HealthCast
Season 1
Episode 23
29m listen
FDA’s Technology Modernization Vision
Share
FDA is modernizing its technology infrastructure to accelerate scientific and regulatory decisions.
-
Amy Abernethy Principal Deputy Commissioner and Acting CIO FDA
Related Content
-
Staying Ahead of AI-Driven Cyber Threats
Robert Roser shares insights on emerging cybercrime trends, supply chain risks and how federal organizations can build stronger security through zero trust.
8m watch -
Marine Corps’ Project Dynamis Speeds AI for Future Battlefield Operations
Col. Arlon Smith shares how Project Dynamis is helping the Marine Corps rapidly field AI capabilities and operate in a future dominated by autonomous systems.
5m listen -
CMS Advances Zero Trust, AI Security in IT Modernization Push
The agency is consolidating platforms to improve security and efficiency.
10m watch -
New OPM Database is First Step for Federal HR Modernization
OPM launched FWD, replacing FedScope with a more transparent, user-friendly platform featuring interactive workforce data.
8m listen
